Search


Third Harmonic Bio is nearing an IND submission to put a new oral KIT inhibitor into the clinic
CEO Natalie Holles describes how learnings from a setback from the company's first asset have resulted in a new program.
Mar 4, 2024
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.